ArticleClinical pharmacology in drug development2024

Pharmacokinetic Properties of an FDA-approved Intranasal Nalmefene Formulation for the Treatment of Opioid Overdose.

Roger Crystal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.